The Pharmacy INformatics Group (PING) at the University of Michigan College of Pharmacy was created with the goal to enable patients and healthcare teams more easily make data-supported decisions about medication use.
Before graduating with his doctorate in medicinal chemistry from the College of Pharmacy last August, Brandt Huddle, PhD, played an instrumental role in the development of a new therapeutic compound for cancer, CM39. The compound inhibits the ability of a key enzyme, aldehyde dehydrogenase (ALDH), to promote chemotherapy resistance in a small pool of cells linked to ovarian cancer.
Simone Brixius-Anderko, Medicinal Chemistry Research Fellow, talks about her American Heart Association award – which will support her search for a new way to treat hypertension and associated cardiac disease. She will also discuss serving as a role model for those from non-academic first careers and inspiring a love of science in the next generation of researchers.